Outcome of Board Meeting

Date: August 14, 2026 The Listing Department National Stock Exchange of lndia Limited, Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai - 400051, Maharashtra. SYMBOL: QMSMEDI Sub: Outcome of Board meeting Re: Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Ma’am, With reference to the captioned subject, we wish to inform that the Board of Directors of the Company in its meeting held today, i.e. on August 14, 2026, have inter-alia considered and approved the following: 1. Unaudited Standalone Financial Results for the Quarter ended June 30, 2026. Please find enclosed: Unaudited Standalone Financial Results of the Company along with Limited Review Report for the Quarter ended June 30, 2026. 2. Unaudited Consolidated Financial Results for the Quarter ended June 30, 2026. Please find enclosed: Unaudited Consolidated Financial Results of the Company along with Limited Review Report for the Quarter ended June 30, 2026. The meeting commenced at 03.00 PM and concluded at 04.00 P.M. This is for your information and records. Thanking you, Yours sincerely, FOR QMS MEDICAL ALLIED SERVICES LIMITED TORAL BHADRA COMPANY SECRETARY AND COMPLIANCE OFFICER MEMBERSHIP NO.: A56927 DATE: AUGUST 14, 2026 PLACE: MUMBAI CIN: L33309MH2017PLC299748; Email ID: mm@qmsmas.com H H Dedhia & Assoc. G&( x INDIA Chartered Accountants Independent Auditor’s report on quarterly unaudited standalone financial results of QMS Medical Allied Services Limited under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended The Board of Directors of QMS Medical Allied Services Limited Introduction 1. We have reviewed the accompanying statement of unaudited standalone financial results (“the Statement”) of QMS Medical Allied Services Limited (“the Company”) for the quarter ended on June 30, 2026, attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“Listing Regulations”). Management’s Responsibility 2. This statement, which is the responsibility of the Company’s Management and approved by the Board of Directors of the Company, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 “Interim Financial Reporting” (“Ind AS 34”) prescribed under section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. Auditor’s Responsibility 3. Our responsibility is to issue a report on the statement based on our review. Scope of Review 4. We conducted our review of the statement in accordance with the Standard on Review Engagements (“SRE”) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity”, issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the statement is free of material misstatement. A review is limited primarily to inquiries of company personnel and analytical and other review procedures applied to financial data and thus provides less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. 803, Sunshine Tower, Senapati Bapat Marg, Prabhadevi, Mumbai - 400 013 Mob : +91 8928074027 / Email : info@hhdas.in H H Dedhia & Assoc. INDIA Chartered Accountants Conclusion 5. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement, prepared in accordance with applicable Ind AS and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. Other Matter 6. The figures for the quarter ended March 31, 2026 are the balancing figures between the audited figures with respect to full previous financial year and the published unaudited year to date figures up to the third quarter of the previous financial year. The figures up to the end of the third quarter of previous financial year had only been subjected to limited review by us. For H H Dedhia & Associates Chartered Accountants (FRN — 148213W) 2l 2= 4 / = Harsh H. Dedhia Proprietor M No. - 141494 UDIN - 26141494NYSWXX9228 Place: Mumbai Date: August 14, 2026 803, Sunshine Tower, Senapati Bapat Marg, Prabhadevi, Mumbai - 400 013 Mob : +91 8928074027 / Email : info@hhdas.in MS MEDI CIN:L33309MH2017PLC299748 " : " abhat Colony 0pp near Santacruz Bus de; t Santacruz East Mumbai 400055, Maharashtra, India Email:mm qmsmas.com Statement of Unaudited Financial Results for the quarter ended 30th June 2026 (Rs. In Lacs) sn Particulars Quartec Baded Year ended 31.03.2026 30.06.2026 31.03.2026 30.06.2025 Unaudited Audited Unaudited Audited T~ [Revenue From Operations (2) [Revenue From Operations (Net oft axes) 523417 391920 423205 15229.73 (b) [Other Income 2464 7.36 1520 3608 Total Income (net) 525881 392656 424725 15,265.81 2 |Expenses (@) [Cost of Material Consumed. - - - - (b) [Purchase of Stock-in-Trade 2,910.64 2,069.82 273130 9.553.42 © g::;;ges in Inventories of Finished Goods. Work in Progress and Stock in (363.52) 127.85 (189.38) (756.39) (@) [Employee Benefits Expenses 1.056.05 51637 26735 129193 (e) [Finance Cost 20482 2712 17727 80066 () |Depreciation and Amortisation Expenses 13053 12155 83.15 41162 (e) [Other Expenses 93050 767.08 78932 303341 Total Expenses 4.869.02 3,840.40 3,850.02 1433465 3 [Profit before exceptional and extraordinary items and tax 389.79 86.16 388.23 93117 4 [Exceptional items 5 [Profit before extraordinary items and tax 389.79 86.16 388.23 93117 6 [Extraordinary items - - - 7 [Profit before tax 389.79 86,16 38823 931, 8 [Tax expense (a) [Current Tax 95.00 7150 9475 277.00 (b) |DeferrTeadx 27.41 (4324)) 2523 (1275) (©) |(ExcessyShort Provision for earlier years - 0.10 - 835 ITotal Tax Expense 12241 2335 11998 272,60 9 [Profit for the period from continuing operations 267.38 6281 26825 65857 10 < Items hat will not be reclassified subsequently to profit ar loss i. Re-measurement of employee defined benefit plans ©.99) 897 ®97) (3538) i. Income tax on (i) above 024 226 226 9.03 (A) (0.71)) (6.71)} {6.71)] (26.85)) Items that will be reclassified subsequently to profit or loss i Fair value of nor-trade investments i. Income tax on (i) above ®) - - - - |Other comprehensive income/ (loss) for the perlod! year, net of tax o o) &) 635 (AYH(B) [T otal comprehensive income for the period/ year (5+6) 266.67 56.10 261.54 63172 11 |Detaoifl s Equity Share Capital Paid up equity share capital (Face value of Rs. L0/~ cach) 1,933.74 193374 1,785.00 193374 Reserve excluding Revaluation Reserves s per balance sheet of previous 807602 accounting year 103 12 [Earnings Per Equity Share (before extraorinary items) (of Rs. 10/-each) (not annualised) (before and after extraordinary items) (@ |Basic & 138 032 148 351 () [Diluted / | 138 032 148 351 [See accompaylying ote to Financial Results FOR QMS MEDICAL ALLIED SERVICES LIMITED Mr. MAHESH PAHALRAJ MAKHIJA Managing Director DIN: 02700606 Date: 14.08.2026 Place: Mumbai Adding Smiles To Life Notes to Standalone Financial Statements 1. Theabove unaudited standalone financial results of the company were reviewed by the Audit Committee & approved by the Board of Directors at its meeting held on 14" August 2026. The review report has been filed with stock exchange and is available on the Company’s website. 2. The results of the Company are available for investors at www.qmsmas.com and www.nseindia.com. 3. The standalone financial results for the quarter ended on 3 [Showing first 8,000 characters — download PDF for full document]